Incorporating substrate features in Fmoc-amino acid-based compounds to generate butyrylcholinesterase inhibitors for the potential treatment of Alzheimer’s disease

Jonathan Godinez

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com